ARKG
ARK Genomic Revolution ETF
1W: +2.0%
1M: -9.0%
3M: -12.3%
YTD: -8.0%
1Y: +11.5%
3Y: -5.0%
5Y: -69.5%
$26.51
-0.35 (-1.30%)
After Hours: $26.71 (+0.20, +0.77%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$1.1B
Holdings22
Top 10 Wt57.7%
Beta2.76
% Profitable12%
Coverage80%
Portfolio Valuation
P/E1175.5
P/B3.8
P/S8.6
EV/EBITDA942.2
P/FCF181.7
PEG40.49
Profitability & Returns
Gross Margin69.0%
Net Margin-57.2%
ROE-26.3%
ROA-17.3%
ROIC-57.2%
Div Yield—%
Leverage & Liquidity
Debt/Equity0.34
Debt/Assets0.22
Net Debt/EBITDA-150.0x
Interest Cov-12.1x
Current Ratio5.76
Quick Ratio5.63
Growth (YoY)
Revenue+24.8%
Net Income+20.8%
EPS+29.0%
FCF-3.5%
EBITDA+33.7%
Rev CAGR 3Y+24.1%
Quality Scores
Piotroski F4.5
Altman Z4.01
IS Quality45.2
IS Overall42.1
IS Value36.8
Median P/E-7.7
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 22 | 79.7% | -16.2 |
| Other | 10 | 20.3% | — |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 32 of 32 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | TEMPUS AI INC-CL A | TEM | 9.31% | $95.9M | 1,970,403 | -32.5 | $8.1B | Healthcare |
| 2 | CRISPR THERAPEUTICS AG | CRSP | 9.28% | $95.6M | 2,004,630 | -7.4 | $4.5B | Healthcare |
| 3 | TWIST BIOSCIENCE CORP | TWST | 8.50% | $87.6M | 1,969,261 | -37.4 | $3.0B | Healthcare |
| 4 | BEAM THERAPEUTICS INC | BEAM | 5.18% | $53.4M | 2,107,977 | -29.9 | $2.4B | Healthcare |
| 5 | PERSONALIS INC | PSNL | 5.14% | $53.0M | 7,610,094 | -8.5 | $684M | Healthcare |
| 6 | 10X GENOMICS INC-CLASS A | TXG | 5.07% | $52.2M | 3,010,393 | -60.2 | $2.7B | Healthcare |
| 7 | ILLUMINA INC Private | — | 4.45% | $45.8M | 372,845 | — | — | — |
| 8 | NATERA INC Private | — | 4.44% | $45.8M | 231,370 | — | — | — |
| 9 | GUARDANT HEALTH INC | GH | 4.07% | $41.9M | 480,554 | -27.3 | $11.4B | Healthcare |
| 10 | RECURSION PHARMACEUTICALS-A | RXRX | 3.84% | $39.5M | 11,911,932 | -2.6 | $1.4B | Healthcare |
| 11 | INTELLIA THERAPEUTICS INC | NTLA | 3.70% | $38.1M | 2,884,623 | -3.5 | $1.6B | Healthcare |
| 12 | CAREDX INC | CDNA | 3.58% | $36.9M | 2,122,393 | -42.1 | $930M | Healthcare |
| 13 | VERACYTE INC | VCYT | 3.32% | $34.3M | 1,029,233 | 39.1 | $2.6B | Healthcare |
| 14 | ABSCI CORP Private | — | 3.13% | $32.2M | 11,273,082 | — | — | — |
| 15 | ADAPTIVE BIOTECHNOLOGIES | ADPT | 2.60% | $26.8M | 2,015,747 | -36.1 | $2.2B | Healthcare |
| 16 | NURIX THERAPEUTICS INC | NRIX | 2.39% | $24.6M | 1,636,206 | -5.6 | $1.3B | Healthcare |
| 17 | GENEDX HOLDINGS CORP | WGS | 2.34% | $24.1M | 340,806 | -79.8 | $2.0B | Healthcare |
| 18 | SCHRODINGER INC | SDGR | 2.31% | $23.8M | 1,986,897 | -8.2 | $842M | Healthcare |
| 19 | IONIS PHARMACEUTICALS INC Private | — | 2.00% | $20.6M | 288,002 | — | — | — |
| 20 | BUTTERFLY NETWORK INC Private | — | 1.98% | $20.4M | 5,168,810 | — | — | — |
| 21 | COMPASS PATHWAYS PLC | CMPS | 1.80% | $18.5M | 3,147,698 | -1.8 | $540M | Healthcare |
| 22 | ARCTURUS THERAPEUTICS HOLDIN | ARCT | 1.63% | $16.8M | 2,558,626 | -2.9 | $201M | Healthcare |
| 23 | PRIME MEDICINE INC | PRME | 1.60% | $16.5M | 4,675,712 | -2.7 | $655M | Healthcare |
| 24 | ATAIBECKLEY INC Private | — | 1.44% | $14.8M | 4,160,046 | — | — | — |
| 25 | PACIFIC BIOSCIENCES OF CALIF | PACB | 1.35% | $13.9M | 10,448,353 | -0.7 | $420M | Healthcare |
| 26 | CERUS CORP Private | — | 1.24% | $12.7M | 7,072,156 | — | — | — |
| 27 | 908 DEVICES INC | MASS | 1.08% | $11.1M | 1,853,390 | 11.3 | $236M | Healthcare |
| 28 | ELI LILLY & CO Private | — | 1.06% | $11.0M | 11,941 | — | — | — |
| 29 | BIONTECH SE-ADR | BNTX | 1.05% | $10.8M | 120,503 | -16.3 | $22.3B | Healthcare |
| 30 | QUANTUM-SI INC | QSI | 0.56% | $5.8M | 6,576,509 | -1.6 | $170M | Healthcare |
| 31 | GENERATE BIOMEDICINES INC Private | — | 0.55% | $5.6M | 477,995 | — | — | — |
| 32 | GOLDMAN FS TRSY OBLIG INST 468 Private | — | 0.04% | $363,016 | 363,016 | — | — | — |